Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Standard BioTools ( (LAB) ).
Standard BioTools Inc. announced that their Chief Commercial Officer, Jeremy Davis, will step down from his position effective February 1, 2025. The company will enter into a severance agreement with Davis, which includes a continuation of salary payments totaling $441,000 over a year, a bonus for the 2024 fiscal year, a pro-rated target bonus, payment of COBRA premiums, and full vesting of equity awards, indicating a structured transition plan for the leadership change.
More about Standard BioTools
YTD Price Performance: 0.0%
Average Trading Volume: 1,802,802
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $651.5M
Learn more about LAB stock on TipRanks’ Stock Analysis page.